TG Therapeutics Announces Data Presentations at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)

NEXT STORY
Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology, Allergy, and Critical Care Division
PREV STORY
Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2016

ROCKVILLE, Md., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...

author_avatar
NASDAQ Market News

Teleflex Reports Second Quarter 2019 Results

author_avatar
NASDAQ Market News

First Stop Health Adds Virtual Primary Care as Whole-Person, Digital-First Service to Address Urgent, Preventive and Chronic Care Needs for Members

author_avatar
NASDAQ Market News